Frequency Modulation Spectroscopy - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Frequency Modulation Spectroscopy
A Novel Nondestructive Approach for Measuring Moisture Activity in Pharmaceutical Samples

Pharmaceutical Technology

The control of moisture in pharmaceutical products is often necessary to prevent deleterious chemical and physical changes to a product. Moisture-driven changes in solid oral dosage forms can have severe adverse effects on pharmaceutical quality. Hence, several measurement approaches for product-moisture content currently are in routine use in the industry. Among the most common means to ascertain moisture levels in solid oral dosage forms are destructive loss-on-drying (LOD) or Karl Fischer (KF) titration techniques. An attractive augmentative approach for examining product moisture would be to directly determine the chemical potential of water in the sample by means of water activity (A w ), which is an arguably more fundamental indicator of the available water for the promotion of chemical, physical, or biochemical change (1–4). The chemical potential of a component in a mixture—such as water—is a fundamental measure of the "escaping tendency" or the availability of the component in the mixture, rather than the total moisture (which may include water that is bound or otherwise unavailable).

At typical storage temperatures and humidities for pharmaceutical solids (5–40 C and <85% relative humidity), water behaves like an ideal gas, and the activity of water in a solid can be related to the headspace relative humidity by the following (5, 6):

A w ~ (PW PWS ) = (relative humidity 100)

in which PW is the partial pressure of water in the headspace, and PWS is the saturated vapor pressure of water at the temperature of interest.

Thus, the relative humidity in the package headspace over a pharmaceutical solid at equilibrium can be directly related to the water activity and is an indication of the amount of water present with potential to cause undesirable changes in the pharmaceutical product.

Currently, two different types of water activity instruments are commercially available: one based on a chilled-mirror dew-point technology to measure humidity and the other based on a polymeric thin-film capacitance sensor that is responsive to headspace moisture. In both of these techniques, the sample of interest is equilibrated in a sealed chamber until equilibrium between the solid and headspace moisture is reached. The chilled-mirror instrument consists of an optical reflectance sensor that detects the exact point at which condensation first appears at the mirror–headspace gas interface. This point is determined by directing a beam of infrared light onto the mirror surface and reflecting the beam of light to a photodetector, which detects reflectance changes upon initiation of condensation. A thermoelectric (Peltier) cooler helps to control the mirror temperature precisely, and a thermocouple attached to the mirror accurately measures the dew-point temperature. Both the dew-point and measured sample-surface temperatures are then used to determine the water activity.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here